← Eichor
Study identifier: NCT07020806 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

[68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC)

Condition: Metastatic Lobular Breast Carcinoma  ·  Sponsor: University of California, Davis

PhasePhase 1
Planned participants30
Who can joinAll sexes, 18 Years to 89 Years
Healthy volunteersNo

About this study

This is a prospective study using \[68Ga\]Ga DOTA-5G PET/CT imaging in patients diagnosed with metastatic/advanced invasive lobular breast cancer (LBC).

This description comes directly from the study's public registry record.

Talk to the study team

Julie Sutcliffe, PhD  ·  916-734-5536  ·  jlsutcliffe@ucdavis.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of California DavisSacramento, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07020806